NHDL, a recombinant V-L/V-H hybrid antibody control for IgG2/4 antibodies

Lau, C; McAdam, MB; Bergseth, G; Grevys, A; Bruun, JA; Ludviksen, JK; Fure, H; Espevik, T; Moen, A; Andersen, JT; Mollnes, TE

Lau, C (corresponding author), Nordland Hosp Trust, Res Lab, Pk Veien 95, N-8092 Bodo, Norway.

MABS, 2020; 12 (1):

Abstract

The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are e......

Full Text Link